RGD-Conjugated Resveratrol HSA Nanoparticles as a Novel Delivery System in Ovarian Cancer Therapy
Qifang Long, Weipei Zhu, Liangsheng Guo, Li Pu Department of Gynecology and Obstetrics, The Second Affiliated Hospital of Soochow University, Suzhou, People’s Republic of ChinaCorrespondence: Weipei Zhu Email weipeizhu@163.comBackground: To establish a novel delivery system of RGD-conjugat...
Saved in:
Main Authors: | Long Q (Author), Zhu W (Author), Guo L (Author), Pu L (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2020-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A Novel Delivery System of RGD-HSA Loaded GEM/CUR Nanoparticles for the Treatment of Pancreatic Cancer Therapy
by: Ma T, et al.
Published: (2022) -
cRGD peptide-conjugated polyethylenimine-based lipid nanoparticle for intracellular delivery of siRNA in hepatocarcinoma therapy
by: Shuang Yang, et al.
Published: (2021) -
Synthesis and Biological Evaluation of RGD-Cryptophycin Conjugates for Targeted Drug Delivery
by: Adina Borbély, et al.
Published: (2019) -
An iRGD‐conjugated photothermal therapy‐responsive gold nanoparticle system carrying siCDK7 induces necroptosis and immunotherapeutic responses in lung adenocarcinoma
by: Rui Cai, et al.
Published: (2023) -
An RGD-Conjugated Prodrug Nanoparticle with Blood-Brain-Barrier Penetrability for Neuroprotection Against Cerebral Ischemia-Reperfusion Injury
by: Ayijiang Taledaohan, et al.
Published: (2024)